AI is making it easier to understand and shape biological systems, and a new commentary argues that people affected by those advances should be able to understand what is being done and help shape decisions. Its proposed framework, called “biotransparency”, sets out practical expectations for communicating the benefits, risks and uncertainties of AI-enabled biology.
Watch Desk analysis
What happened
The commentary in The Scientist argues that information about consequential AI-and-biology work should be accessible, understandable and shared early enough for affected people to take part. It proposes seven tenets: remove financial, language and disability barriers; explain benefits, risks, uncertainties and safeguards in plain terms; describe when effects might occur and, where possible, their likelihood and scale; allow time for meaningful participation; consider how benefits and risks are distributed; and disclose relevant conflicts of interest.
The proposal is not presented as a new regulatory requirement. It calls instead for a proportionate culture of communication: a researcher using AI to identify proteins would not automatically need a public-engagement campaign, while work with potentially far-reaching effects beyond the laboratory could warrant much more.
Why it matters
AI-enabled biology is not just a technical question for researchers. Its effects could reach patients, communities, animals and the environment, while the people who bear those effects may have little say in how projects proceed. The framework asks institutions to explain what is known, what remains uncertain and what safeguards exist before decisions are already made.
That does not mean publishing every sensitive detail. The commentary recognises that biosecurity, privacy and legitimate commercial interests can restrict disclosure. The harder question is how to protect those interests without leaving affected people with a glossy promise and a very large blank space.
Our read
The useful idea here is proportionality: the greater the potential impact beyond the lab, the stronger the case for clear information and meaningful participation. That is more practical than treating every AI-and-biology project as either harmless research or a public emergency.
The test will be whether organisations give people information they can actually use, early enough to influence decisions. “We communicated” is a low bar if the message arrived in jargon after the important choices were settled.
What to watch
- Whether research institutions adopt concrete guidance based on the proposed tenets.
- How organisations balance public understanding with privacy, proprietary information and biosecurity.
- Whether affected communities get a real opportunity to influence decisions, rather than simply receive an update.
Discussion spark: For AI-enabled biology with possible effects beyond the lab, what should trigger meaningful public participation, and who should decide?
Sources and evidence
- Biotransparency Gives Society a Voice in Shaping Its Biological Future (13 November 2026, 00:00 UTC)
Watch Desk is operated by WittyWires as an independent cross-cutting AI news tracker. It does not speak for the organisations or people it covers.